$ALNT

WARZALA RICHARD S sold $8.0M of ALNT

WARZALA RICHARD S (Chief Executive Officer) sold 70,000 shares of ALLIENT INC (ALNT) at an average of $113.58 ($112.81–$115.35, $7.95M total) across 4 trades on 2026-08-10.

Original reporting
SEC EDGAR · WARZALA RICHARD S
Published Aug 12, 2026, 9:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALNT
Neutral
medium confidence
Mentioned
$ALNT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALNTNeutralLow
01

Why it matters

This provides a datapoint on insider behavior (open-market sale, no 10b5-1 plan stated) but does not include any new operational or financial guidance.

02

Market read

Traders may monitor insider activity, but the disclosure alone is unlikely to change valuation without accompanying fundamental news.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; the filing lacks any stated reason or linkage to performance.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-12 after-hours; sale executed 2026-08-10

Background

The article is a SEC Form 4 insider transaction disclosure for ALLIENT (ALNT) by its CEO.

Company-level read

Ticker impact

$ALNTNeutralMedium confidence
Context

CEO WARZALA RICHARD S sold about $7.95M of ALLIENT shares in an open-market Form 4 transaction dated 2026-08-10.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size and pricing but no earnings, guidance, or operational change.

Market effects

No sector-level signal; this is company-specific insider selling.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted by some traders as less routine, potentially increasing short-term skepticism.

Key entities

  • ALLIENT INC

    Company whose CEO filed the Form 4 insider sale disclosure.

  • WARZALA RICHARD S

    ALLIENT CEO and director who sold 70,000 shares across four trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AEISMed

Electronic Components Stocks Q2 Results: Benchmarking Advanced Energy (NASDAQ:AEIS)

Eight electronic components stocks reported Q2 revenues 3.3% above estimates, with next quarter's guidance 6.9% higher. Despite strong results, shares fell 7.2% on average. Advanced Energy (AEIS) saw $574.1M revenue (up 30% YoY, 5.6% beat), but its stock dropped 10%. Allient (ALNT) and Littelfuse (LFUS) also beat estimates, while nLIGHT (LASR) missed EBITDA guidance, falling 46.4%.

$ALNTHighAI 8/10

Q2 Electronic Components Earnings: Allient (NASDAQ:ALNT) Impresses

Allient (ALNT) reported Q2 revenue of $153.8M, up 10.2% YoY, beating estimates by 5.5%. The company's stock is flat since reporting. Advanced Energy (AEIS) saw 30% YoY revenue growth, outperforming expectations by 5.6%, but its stock fell 6.1%. nLIGHT (LASR) reported 33.8% YoY revenue growth, beating estimates by 4.6%, but its stock dropped 44%. Belden (BDC) reported 11.6% YoY revenue growth, in line with expectations, and its stock rose 12.5%. Bel Fuse (BELF.A) saw 25.2% YoY revenue growth, bea

$ALNTMed

The Bull Case For Allient (ALNT) Could Change Following Its Zacks Rank Upgrade And Earnings Boost

Allient Inc. (ALNT) was upgraded to Zacks Rank #1 (Strong Buy) after its consensus earnings estimate rose 10.5% in 60 days, driven by strong Q2 2026 results. Analysts are optimistic about its precision motion and power solutions business, despite industry weakness. The company projects $671.5M revenue and $48.7M earnings by 2029, requiring 6.2% annual revenue growth.

$ALNTMed

Allient (ALNT) Q2 2026 Earnings Call Transcript

Allient (ALNT) Q2 2026 earnings call said revenue rose 10% year over year to $153.8 million, with data center and infrastructure sales of $16.3 million (10.6% of revenue), up 60% YoY. Gross margin increased 170 bps to a record 34.9%, driven by mix and operational gains tied to its STAN program. Industrial, Aerospace & Defense, and Medical grew; Vehicle declined.

$ALNTMedAI 8/10

Allient’s (NASDAQ:ALNT) Q2 CY2026: Strong Sales

Allient (NASDAQ:ALNT) reported Q2 CY2026 results. Revenue rose 10.2% year on year to $153.8 million, exceeding Wall Street estimates by 5.5%. Non-GAAP adjusted EPS was $0.80, up from $0.57 a year earlier and above consensus. Analysts expect revenue growth of 6.3% over the next 12 months and full-year EPS to rise from $2.44 to $2.91.